BiomX (PHGE) Current Assets (2018 - 2026)
BiomX (PHGE) posted Current Assets of $3.0 million for Q1 2026, down 45.42% sequentially from $5.6 million in Q4 2025, and down 87.07% YoY from $23.5 million in Q1 2025.
BiomX (PHGE) Current Assets (2018 - 2026) Analysis & Trends
BiomX has reported Current Assets for 9 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Current Assets fell 87.07% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 87.07% YoY) and the FY2025 annual result came in at $5.6 million, down 72.83% from the prior year.
- Current Assets eased to $3.0 million in Q1 2026 per PHGE's latest filing, from $5.6 million in the prior quarter.
- Over five years, Current Assets peaked at $58.1 million in Q1 2022 and troughed at $3.0 million in Q1 2026.
- A 5-year average of $27.3 million and a median of $26.8 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2026: Current Assets advanced 16.38% in 2024, then sank 87.07% in 2026.
- Over 5 years, Current Assets stood at $36.9 million in 2022, then tumbled by 52.19% to $17.6 million in 2023, then rose by 16.38% to $20.5 million in 2024, then plunged by 72.83% to $5.6 million in 2025, then slumped by 45.42% to $3.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $3.0 million, $5.6 million, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | 8.86 Mn |
| Jun 30, 2025 | 16.64 Mn |
| Mar 31, 2025 | 23.53 Mn |
| Dec 31, 2024 | 20.52 Mn |
| Sep 30, 2024 | 28.32 Mn |
| Jun 30, 2024 | 35.08 Mn |
| Dec 31, 2023 | 17.63 Mn |
| Sep 30, 2023 | 25.30 Mn |
| Jun 30, 2023 | 33.19 Mn |
| Mar 31, 2023 | 32.93 Mn |
| Dec 31, 2022 | 36.88 Mn |
| Sep 30, 2022 | 42.53 Mn |
| Jun 30, 2022 | 48.31 Mn |
| Mar 31, 2022 | 58.11 Mn |
| Dec 31, 2021 | 66.64 Mn |
| Sep 30, 2021 | 69.80 Mn |
| Jun 30, 2021 | 49.84 Mn |
| Mar 31, 2021 | 56.54 Mn |